Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis. (Q37856911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Nam-Kyong Choi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

C W Rhee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

B J Park

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

24 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

247-254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431993%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Alendronate and atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Relation of bisphosphonate therapies and risk of developing atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Atrial fibrillation in fracture patients treated with oral bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Bisphosphonates and atrial fibrillation: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Bisphosphonate use in women and the risk of atrial fibrillation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Review of osteoporosis pharmacotherapy for geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Use of alendronate and risk of incident atrial fibrillation in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Relationship between osteoporosis and cardiovascular disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Bisphosphonates: an overview with special reference to alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Molecular mechanisms of action of bisphosphonates: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Aortic atherosclerotic disease and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Long-term use of bisphosphonates in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Bisphosphonates: mode of action and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Bone safety of long-term bisphosphonate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1608-Z

Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate

21 January 2018

1 reference

12 December 2020

Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits

1 reference

12 December 2020

Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk

1 reference

12 December 2020

The association between low bone mass at the menopause and cardiovascular mortality

1 reference

12 December 2020

Effects of bisphosphonates on lipid metabolism

1 reference

12 December 2020

Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro

1 reference

12 December 2020